Argentina Nuclear Medicine Market Size & Outlook

The nuclear medicine market in Argentina is expected to reach a projected revenue of US$ 94.3 million by 2030. A compound annual growth rate of 9.7% is expected of Argentina nuclear medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$49.3
Forecast, 2030 (US$M)
$94.3
CAGR, 2024 - 2030
9.7%
Report Coverage
Argentina

Argentina nuclear medicine market, 2018-2030 (US$M)

Argentina

Argentina nuclear medicine market highlights

  • The Argentina nuclear medicine market generated a revenue of USD 49.3 million in 2023 and is expected to reach USD 94.3 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 9.7% from 2024 to 2030.
  • In terms of segment, diagnostics was the largest revenue generating product in 2023.
  • Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.


Nuclear medicine market data book summary

Market revenue in 2023USD 49.3 million
Market revenue in 2030USD 94.3 million
Growth rate9.7% (CAGR from 2023 to 2030)
Largest segmentDiagnostics
Fastest growing segmentTherapeutics
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics
Key market players worldwideGE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.5% of the global nuclear medicine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil nuclear medicine market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 218.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nuclear Medicine Market Companies

Name Profile # Employees HQ Website

Argentina nuclear medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.


Diagnostics was the largest segment with a revenue share of 80.93% in 2023. Horizon Databook has segmented the Argentina nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


INVAP, a nuclear technology company in Argentina, entered into an agreement with the Bolivian Nuclear Energy Agency for the supply of radiotherapy and nuclear medicine centers in the El Alto, Santa Cruz de la Sierra, and La Paz. The agreement was supported by the Argentine Foreign Ministry.

In addition, in April 2018, Rosatom, a Russian company, signed a contract with Laboratorios Bacon, a company based in Argentina, for weekly supply of Mo-99. The contract was aimed toward meeting the growing demand for Mo-99 in Argentina.

Reasons to subscribe to Argentina nuclear medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Argentina nuclear medicine market databook

  • Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into Argentina nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Argentina nuclear medicine market size, by product, 2018-2030 (US$M)

Argentina Nuclear Medicine Market Outlook Share, 2023 & 2030 (US$M)

Argentina nuclear medicine market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more